<DOC>
	<DOCNO>NCT01268176</DOCNO>
	<brief_summary>This study seek determine vitamin D3 absorption healthy adult enhance presence meal enhancement great meal low oppose high fat content . The enhancement result increase vitamin D absorption . The investigator test hypothesis pursue follow aim 3-mo trial 70 healthy men woman randomize one follow meal condition take monthly oral dose 50,000 IU vitamin D3 : meal ( fast ) , low fat meal , high fat meal . The Primary Aim identify meal condition ( fasting , low-fat , high-fat meal ) 25OHD3 response supplemental vitamin D3 great consistent . The Secondary Aim determine whether vitamin D3 absorption affect meal condition determine whether absorption vitamin D3 predict longer-term 25OHD3 response supplementation .</brief_summary>
	<brief_title>The Effect Meal Vitamin D Absorption</brief_title>
	<detailed_description>Vitamin D supplement increasingly recommend curb widespread deficiency . Decreasing variability 25OHD response supplemental vitamin D would make supplementation process predictable , thereby reduce number 25OHD measurement dose adjustment need achieve target 25OHD level . This study seek identify potential source variability 25OHD3 response supplemental vitamin D3 plausible base rat study , explore human . The investigator hypothesize serum 25OHD3 response supplemental vitamin D3 healthy adult enhance presence meal enhancement great meal low oppose high fat content . The enhancement result increase vitamin D absorption . The investigator test hypothesis pursue follow aim 3-mo trial 70 healthy men woman randomize one follow meal condition take monthly oral dose 50,000 IU vitamin D3 : meal ( fast ) , low fat meal , iso-caloric high fat meal . Serum 25OHD3 measure baseline 1 3 mo . A serum vitamin D3 absorption test perform subject first dose vitamin D. The Primary Aim identify meal condition ( fasting , low-fat , high-fat meal ) 25OHD3 response supplemental vitamin D3 great consistent . The Secondary Aim determine whether vitamin D3 absorption affect meal condition determine whether absorption vitamin D3 predict longer-term 25OHD3 response supplementation .</detailed_description>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Ages 50 69 BMI ≥ 18.5 ≤ 27.9 kg/m2 take ≤ 400 IU/day vitamin D3 ≤ 1000 mg calcium/day participate must agree change dietary supplemental vitamin D calcium intake study use tan salon travel south latitude 34 degree north study General : 1 . A screen 25OHD level ≤8 ≥ 25 ng/ml 2 . An abnormal serum calcium ( reference range 8.3 10.2 mg/dl ) 3 . A screen spot urinary calcium : creatinine ratio &gt; 0.325 4 . Greater 2 drink alcohol day . 5 . BMI &lt; 18.5 &gt; 27.9 kg/m2 6 . Menses within last year ( woman ) 7 . Age &lt; 50 &gt; 69 year 8 . Allergy egg 9 . A blood donation last 2 month ( increase likelihood anemia ) 10 . NonEnglish speaking subject enrol . 11 . Other abnormality screen lab , discretion study physician ( PI ) Medications : 1 . Subjects must agree take 400 IU per day vitamin D supplement cod liver oil study 2 . Topical vitamin D preparation 3 . Oral estrogen estrogen patch use last 6 month 4 . Regular antacid use ( &gt; 2 time per week ) 5 . Sucralfate 6 . Acarbose/miglitol 7 . PPIs prescription : lansoprazole ( Prevacid ) , omeprazole ( Prilosec Zegerid ) , esomeprazole ( Nexium ) , rabeprazole ( Aciphex ) , pantoprazole ( Protonix ) ; overthecounter : lansoprazole ( Prevacid 24 ) , omeprazole ( Prilosec OTC ) , zegerid OTC ( Equate ) , omeprazole magnesium 8 . H2 blocker prescription : cimetidine ( Tagamet ) , famotidine ( Pepsid ) , nizatidine ( Axid ) , rantidine hydrochloride ( Zantac ) , dexlansoprazole ( Kapidex ) ; counter : cimetidine ( TagametHB , Equate ) , famotidine ( PepcidAC , Pepcid Complete ) , rantidine hydrochloride ( Zantac , WalZan , Equate ) 9 . Drugs alter fat cholesterol handle xenical alli ( Orlistat ) , cholestyramine ( Questran , LoCholest , Prevalite ) , Zetia 10 . Drugs alter 25OHD metabolism Antiseizure drug phenobarbitol phenytoin ( Dilantin ) , oral glucocorticoid 11 . Calcium supplement use &gt; 1000 mg/day Diseases : 1 . Active parathyroid disease 2 . Sarcoidosis 3 . Peptic ulcer esophageal stricture 4 . Active malignancy ( basal cell cancer skin ) cancer therapy last year 5 . Advanced kidney disease ( creatinine clearance &lt; 30 ml/min calculate serum creatinine use Modification Diet Renal Disease ( MDRD ) Study equation 6 . Kidney stone last 5 year . 7 . Liver disease 8 . ZollingerEllison syndrome 9 . Known achlorhydria small bowel overgrowth 10 . Malabsorption 11 . Diseases associate fat malabsorption liver disease , cystic fibrosis , Celiac disease , bariatric surgery , Scleroderma , Crohn 's , prior surgery involve stomach small bowel ( appendectomy okay ) , gall stone prior gall bladder surgery , pancreatitis</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Vitamin D</keyword>
	<keyword>vitamin D deficiency</keyword>
	<keyword>vitamin D absorption</keyword>
</DOC>